Adverse drug event-related emergency department visits associated with complex chronic conditions

James A Feinstein1, Chris Feudtner2, Allison Kempe3

  • 1Children's Outcomes Research Program, Children's Hospital Colorado, Aurora, Colorado;Division of General Pediatrics, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado; and james.feinstein@ucdenver.edu.

Pediatrics
|May 21, 2014
PubMed

Insights

Children with complex chronic conditions (CCCs) have higher rates of emergency department visits for adverse drug events (ADEs). While implicated medications differ, CCC status did not increase the risk of hospital admission following an ADE.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacovigilance
  • Chronic Disease Management

Background:

  • Outpatient adverse drug events (ADEs) are a significant cause of emergency department (ED) visits and hospitalizations.
  • The impact of ADEs on children with complex chronic conditions (CCCs), who are often on multiple medications, is not well understood.

Purpose of the Study:

  • To characterize ADE-related ED visits in children, focusing on the association with CCC status.
  • To identify medications implicated in ADEs among children.
  • To determine if CCC status influences the risk of admission following an ADE-related ED visit.

Main Methods:

  • Retrospective cohort study utilizing a national sample of pediatric ED visits (ages 0-18).
  • ADEs identified using external cause of injury codes; excluded cases of overdose, wrongful administration, self-harm, or malignancy.
  • Multivariable logistic regression analyzed the association between CCC status and ADE-related ED visits and subsequent admissions, accounting for survey design.

Main Results:

  • 0.5% of 144 million ED visits were linked to ADEs.
  • Children with CCCs had a significantly higher likelihood of ADE-related ED visits (OR 4.76).
  • Implicated medications varied significantly between children with and without CCCs, but CCC status did not significantly alter the odds of admission post-ADE (OR 2.18 for all children).

Conclusions:

  • Children with CCCs are more prone to ADE-related ED visits, with distinct medication profiles.
  • Despite increased ED visits for ADEs, complex chronic condition status did not independently increase the risk for hospital admission.
Abstract

Related Concept Videos

Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare settings,...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...